SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?


To: Stephen How who wrote (717)2/19/1998 4:06:00 PM
From: Bill Wexler  Respond to of 1432
 
Sorry Steve but I am now a Biotime LONG.

The Canadians don't matter. The U.S. market alone will probably be over $20 Billion a year. Not only is Hextend going to replace Hespan and albumin, but my sources tell me that Biotime scientists have successfully resuscitated people who've been dead over a week! I estimate this additional raising-the-dead market to be over $50 Billion a year.

Gooooooo Biotime!!!